RBC Capital Markets raised its price target for Aviva PLC to 790p from 780p, maintaining an 'outperform' rating despite lowering near-term earnings forecasts due to higher catastrophe losses in Canada. The broker cut its 2026 operating profit forecast by about 20% for Canadian insurance and reduced the 2026 operating EPS estimate by 4%, expecting a £160 million impact from natural disaster claims. However, RBC raised profit forecasts for 2027 and 2028, driven by strong growth in Aviva's wealth business, which is expected to generate over £500 million operating profit by 2032. The revised target implies about 10% upside from the previous close, reflecting confidence in Aviva's balanced insurance portfolio and earnings growth potential.
Aviva's recent price target update provides context for financial market watchers. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 23, 2026 19:12 WIB: out of 142 priced US Financials stocks, 38 rose and 96 fell. Notable movers include BX at USD 116.72 with a 1-day change of -1.71% and a typical hold time on Pluang of 97 days, NWG at USD 16.71 down 1.65%, and MFG at USD 9.55 down 1.65%.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
